WBR0442: Difference between revisions
Jump to navigation
Jump to search
Rim Halaby (talk | contribs) Created page with "{{WBRQuestion |QuestionAuthor={{Rim}} |ExamType=USMLE Step 1 |MainCategory=Pharmacology |SubCategory=Cardiology |MainCategory=Pharmacology |SubCategory=Cardiology |MainCategor..." |
No edit summary |
||
| Line 1: | Line 1: | ||
{{WBRQuestion | {{WBRQuestion | ||
|QuestionAuthor={{Rim}} | |QuestionAuthor={{Rim}} {{Alison}} | ||
|ExamType=USMLE Step 1 | |ExamType=USMLE Step 1 | ||
|MainCategory=Pharmacology | |MainCategory=Pharmacology | ||
| Line 20: | Line 20: | ||
|MainCategory=Pharmacology | |MainCategory=Pharmacology | ||
|SubCategory=Cardiology | |SubCategory=Cardiology | ||
|Prompt=A researcher | |Prompt=A researcher, assessing difference between the intravenous (i.v.) and the oral forms of metoprolol using mice, administers both drugs to the mice and notes the following plasma concentrations of the medications illustrated in the graph below. Which of the following equations best corresponds to the bioavailability (F) of metoprolol in the oral form? | ||
[[Image:WBR Bioavailability.png]] | [[Image:WBR Bioavailability.png]] | ||
|Explanation=[[Bioavailability]] (F) is defined as the proportion of the total area under the plasma concentration-time curve (AUC). The relative bioavailability of the oral form of a drug can be calculated using the following equation: F = (AUCoral / AUCi.v.) x | |Explanation=[[Bioavailability]] (F) is defined as the proportion of the total area under the plasma concentration-time curve (AUC). The relative [[bioavailability]] of the oral form of a drug can be calculated using the following equation: F = (AUCoral / AUCi.v.) x (Dosei.v./Doseoral) | ||
|EducationalObjectives= | |||
Bioavailability | Bioavailability can be calculated with the following equation: F = (AUCoral / AUCi.v.) x (Dosei.v./Doseoral) | ||
|References= First Aid 2014 page 239 | |||
|AnswerA=F = (AUCoral / AUCi.v.) x | |AnswerA=F = (AUCoral / AUCi.v.) x (Dosei.v./Doseoral) | ||
|AnswerAExp=Bioavailability can be calculated using the equation: F = (AUCoral / AUCi.v.) x | |AnswerAExp=Bioavailability can be calculated using the equation: F = (AUCoral / AUCi.v.) x (Dosei.v./Doseoral) | ||
|AnswerB=(AUCoral / Doseoral ) x (AUCi.v. x Dosei.v.) | |AnswerB=(AUCoral / Doseoral ) x (AUCi.v. x Dosei.v.) | ||
|AnswerBExp= | |AnswerBExp=This equation is not used to calculate bioavailability. | ||
|AnswerC=(AUCi.v. / AUCoral) x (Doseoral x Dosei.v.) | |AnswerC=(AUCi.v. / AUCoral) x (Doseoral x Dosei.v.) | ||
|AnswerCExp= | |AnswerCExp=This equation is not used to calculate bioavailability. | ||
|AnswerD=(Doseoral x AUCoral) x (Dosei.v. x AUCi.v.) | |AnswerD=(Doseoral x AUCoral) x (Dosei.v. x AUCi.v.) | ||
|AnswerDExp= | |AnswerDExp=This equation is not used to calculate bioavailability. | ||
|AnswerE=(AUCoral + Doseoral) / (AUCi.v. + Dosei.v.) | |AnswerE=(AUCoral + Doseoral) / (AUCi.v. + Dosei.v.) | ||
|AnswerEExp= | |AnswerEExp=This equation is not used to calculate bioavailability. | ||
|RightAnswer=A | |RightAnswer=A | ||
|WBRKeyword=Bioavailability, pharmacokinetics, pharmacodynamics, oral, intravenous | |WBRKeyword=Bioavailability, pharmacokinetics, pharmacodynamics, oral, intravenous, equation, formula, calculation | ||
|Approved= | |Approved=Yes | ||
}} | }} | ||
Revision as of 14:44, 23 July 2014
| Author | [[PageAuthor::Rim Halaby, M.D. [1] (Reviewed by Alison Leibowitz)]] |
|---|---|
| Exam Type | ExamType::USMLE Step 1 |
| Main Category | MainCategory::Pharmacology |
| Sub Category | SubCategory::Cardiology |
| Prompt | [[Prompt::A researcher, assessing difference between the intravenous (i.v.) and the oral forms of metoprolol using mice, administers both drugs to the mice and notes the following plasma concentrations of the medications illustrated in the graph below. Which of the following equations best corresponds to the bioavailability (F) of metoprolol in the oral form?
|
| Answer A | AnswerA::F = (AUCoral / AUCi.v.) x (Dosei.v./Doseoral) |
| Answer A Explanation | AnswerAExp::Bioavailability can be calculated using the equation: F = (AUCoral / AUCi.v.) x (Dosei.v./Doseoral) |
| Answer B | AnswerB::(AUCoral / Doseoral ) x (AUCi.v. x Dosei.v.) |
| Answer B Explanation | AnswerBExp::This equation is not used to calculate bioavailability. |
| Answer C | AnswerC::(AUCi.v. / AUCoral) x (Doseoral x Dosei.v.) |
| Answer C Explanation | AnswerCExp::This equation is not used to calculate bioavailability. |
| Answer D | AnswerD::(Doseoral x AUCoral) x (Dosei.v. x AUCi.v.) |
| Answer D Explanation | AnswerDExp::This equation is not used to calculate bioavailability. |
| Answer E | AnswerE::(AUCoral + Doseoral) / (AUCi.v. + Dosei.v.) |
| Answer E Explanation | AnswerEExp::This equation is not used to calculate bioavailability. |
| Right Answer | RightAnswer::A |
| Explanation | [[Explanation::Bioavailability (F) is defined as the proportion of the total area under the plasma concentration-time curve (AUC). The relative bioavailability of the oral form of a drug can be calculated using the following equation: F = (AUCoral / AUCi.v.) x (Dosei.v./Doseoral) Educational Objective: Bioavailability can be calculated with the following equation: F = (AUCoral / AUCi.v.) x (Dosei.v./Doseoral) |
| Approved | Approved::Yes |
| Keyword | WBRKeyword::Bioavailability, WBRKeyword::pharmacokinetics, WBRKeyword::pharmacodynamics, WBRKeyword::oral, WBRKeyword::intravenous, WBRKeyword::equation, WBRKeyword::formula, WBRKeyword::calculation |
| Linked Question | Linked:: |
| Order in Linked Questions | LinkedOrder:: |
